Provision of an Existing Antimicrobial to the NHS in England via a Subscription-based Payment Model

Concepts

• nhs
• leeds
• general anti-infectives
• england
• supply of the selected antimicrobial
• nhs england
• number of antimicrobials
• provision of an existing antimicrobial
• public health england
• subscription

Location

United Kingdom: UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, UKK - England

Description

NHS England has appointed a supplier with the capability to supply an existing antimicrobial to the NHS in England via a subscription-based payment model.

Total Quantity or Scope

This procurement was conducted by NHS England. The contract entered into pursuant to this procurement is between the successful supplier and NHS England ( previously the National Health Service Commissioning Board).Organisations wishing to participate in the procurement had to have at least one EU licensed antimicrobial that had a UK launch dated on or between 1 January 2017 and 31 December 2019 and that was active against one or more pathogens on the World Health Organisation priority pathogen list.There were no limits on the number of antimicrobials that an organisation could offer.Contracts awarded pursuant to the procurement are for use by the Department of Health and Social Care, Public Health England, the NHS in England, and by private sector healthcare contractors and agents working on behalf of the aforementioned.The successful supplier is responsible for supply of the selected antimicrobial from 1 July 2022.The duration of any contract awarded is for an initial period of three (3) years, with the option to extend (by mutual agreement) for an additional period or periods up to seven (7) years. Additional information: The award criteria were set out in the procurement documents. They are also available on the NICE website: https://www.nice.org.uk/Media/Default/About/what-we-do/Life-sciences/award-quest...

Award Detail

Award Criteria

CPV Codes

• 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
• 33651000 - General anti-infectives for systemic use and vaccines

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Note that the contract value stated (£100 million) is not the exact contract value, as this cannot be published for reasons of confidentiality / damage to commercial interests. However, the contract value is broadly commensurate with the advertised value of £100 million